Biotech · Private company
Noveome Biotherapeutics, formerly Stemnion
Track this companyFree. Adds Noveome Biotherapeutics, formerly Stemnion to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- 0.67% Sodium Chloride Ophthalmic SolutionPhase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Open-label ST266Phase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · Third Degree BurnsClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · BurnsClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · Necrotizing EnterocolitisClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · Periodontal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Refresh Lubricant Eye DropsPhase 1 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 1 · Radiation-induced DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 1 · Cytokine Release SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ST266Phase 1 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ST266 via Intranasal DeliveryPhase 1 · Ocular HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)PHASE1_PHASE2 · RECRUITING · started Aug 19, 2024ClinicalTrials.gov NCT06315738 · fetched Nov 12, 2026
- ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial DefectsPHASE2 · TERMINATED · started Apr 27, 2022ClinicalTrials.gov NCT05066698 · fetched Nov 12, 2026
- Safety and Tolerability Study of IV ST266 in COVID-19 SubjectsPHASE1 · COMPLETED · started May 30, 2021ClinicalTrials.gov NCT04720378 · fetched Nov 12, 2026
- Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect SubjectsPHASE1 · COMPLETED · started Oct 23, 2019ClinicalTrials.gov NCT03901781 · fetched Nov 12, 2026
- ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial DefectsPHASE2 · COMPLETED · started Jun 10, 2019ClinicalTrials.gov NCT03687632 · fetched Nov 12, 2026
- Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic ConjunctivitisPHASE2 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02978183 · fetched Nov 12, 2026
- Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe PeriodontitisPHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02761993 · fetched Nov 12, 2026
- Study of ST266 Eye Drops in Treating Dry EyePHASE1 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02369861 · fetched Nov 12, 2026
- Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin GraftsPHASE2 · TERMINATED · started Oct 1, 2012ClinicalTrials.gov NCT01715012 · fetched Nov 12, 2026
- Study of ST266 Versus Saline in Treating Skin Irritation From RadiationPHASE1 · COMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01714973 · fetched Nov 12, 2026
- ST266 Versus Standard Care In Treating Partial Thickness BurnsPHASE1_PHASE2 · TERMINATED · started Jun 1, 2009ClinicalTrials.gov NCT00886470 · fetched Nov 12, 2026